Munehiro Kitada

Kimiidera, 6418509, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Impact of impaired branched-chain amino acid metabolism on kidney disease.

Impact of impaired branched-chain amino acid metabolism on kidney disease.

Journal: Clinical science (London, England : 1979)

Published: March 31, 2026

Nationwide questionnaire survey on collaboration for the management of chronic kidney disease from the perspective of referrals in Japan.

Nationwide questionnaire survey on collaboration for the management of chronic kidney disease from the perspective of referrals in Japan.

Journal: Clinical and experimental nephrology

Published: February 12, 2026

Nationwide questionnaire analysis on awareness of general practitioners for the management of chronic kidney disease in Japan.

Nationwide questionnaire analysis on awareness of general practitioners for the management of chronic kidney disease in Japan.

Journal: Clinical and experimental nephrology

Published: December 10, 2025

A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating Behavior.

A Case of Slowly Progressive Type 1 Diabetes Mellitus (SPIDDM, Probable) Successfully Managed With Oral Semaglutide for Glycemic Control and Weight Management Accompanied by Changes in Eating Behavior.

Journal: Cureus

Published: November 07, 2025

Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE.

Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE.

Journal: Kidney international reports

Published: October 31, 2025

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open-label clinical trial (RESOLUTION study).

Journal: Journal of diabetes investigation

Published: May 20, 2025

A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.

A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.

Journal: Kidney international

Published: March 03, 2024

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research.

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research.

Journal: Cells

Published: January 07, 2023

Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.

Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.

Journal: Diabetes, obesity & metabolism

Published: January 21, 2022

Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches.

Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches.

Journal: Journal of clinical medicine

Published: December 01, 2021

Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice.

Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice.

Journal: Journal of diabetes investigation

Published: November 18, 2021

Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats.

Exercise Ameliorates Diabetic Kidney Disease in Type 2 Diabetic Fatty Rats.

Journal: Antioxidants (Basel, Switzerland)

Published: October 14, 2021

Showing 1-12 of 96

Last Updated: 09/26/2026